Agilvax Inc-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014253)
◆英語タイトル:Agilvax Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014253
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Agilvax Inc (Agilvax) is a drug company that discovers and develops vaccines against infectious diseases and immunotherapies to treat cancer. The company develops products based on a proprietary virus-like particle platform technology. It develops immunotherapies to treat breast cancer, lung cancer and melanoma. Agilvax develops AX03, a lead vaccine candidate, for human papilloma virus prevention. The company also develops vaccines against infectious diseases such as respiratory syncytial virus, malaria and dengue. It evaluates its lead immunotherapy candidates through in vitro and in vivo tests for clinical efficacy. The company also partners with industry, academia, and government institutions for developing immunotherapies and vaccines. Agilvax is headquartered in Albuquerque, New Mexico, the US.

Agilvax Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Agilvax Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Agilvax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Agilvax Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Agilvax Raises USD2 Million in Series A Venture Financing 10
AgilVax Raises USD1 Million in Venture Financing 11
Agilvax, Developer Of Vaccines, To Raise US$2 Million In Venture Financing 12
Partnerships 13
Agilvax Enters into Co-Development Agreement with Integrated BioTherapeutics 13
Agilvax Enters into Co-Development Agreement with Sandia National Labs 14
Agilvax Enters into Development Agreement with Humabs Biomed 15
Licensing Agreements 16
Agilvax Enters into Licensing Agreement with STC.UNM 16
Agilvax Inc – Key Competitors 17
Agilvax Inc – Key Employees 18
Agilvax Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Sep 14, 2016: Faith Charles Joins Agilvax’s Board Of Directors 20
Jul 20, 2016: Agilvax Appoints Dr. Brad Vale Former Head of Johnson & Johnson Development Corporation (JJDC) to its Board Of Directors 21
Product News 22
07/06/2016: Agilvax Receives SBIR Grant To Advance Development Of A VLP Based RSV Vaccine 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Agilvax Inc, Pharmaceuticals & Healthcare, Key Facts 2
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Agilvax Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Agilvax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Agilvax Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Agilvax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Agilvax Raises USD2 Million in Series A Venture Financing 10
AgilVax Raises USD1 Million in Venture Financing 11
Agilvax, Developer Of Vaccines, To Raise US$2 Million In Venture Financing 12
Agilvax Enters into Co-Development Agreement with Integrated BioTherapeutics 13
Agilvax Enters into Co-Development Agreement with Sandia National Labs 14
Agilvax Enters into Development Agreement with Humabs Biomed 15
Agilvax Enters into Licensing Agreement with STC.UNM 16
Agilvax Inc, Key Competitors 17
Agilvax Inc, Key Employees 18

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Agilvax Inc-製薬・医療分野:企業M&A・提携分析(Agilvax Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆